Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-15

FDA Approved: JAVYGTOR — Original Application (Dr. Reddys Laboratories Inc)

View source ↗

Summary

FDA approved JAVYGTOR (sapropterin dihydrochloride) from Dr. Reddy's Laboratories as an original ANDA, providing a generic option for phenylketonuria in BH4-res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • JAVYGTOR (Sapropterin dihydrochloride)

Snippet

ORIG AP for JAVYGTOR (SAPROPTERIN DIHYDROCHLORIDE)